Two new therapies for advanced prostate cancer reflect the enthusiasm that doctors hold for the future treatment of this disease.
CANCER of the prostate (CaP) is the most common cancer (other than skin cancer) in males in Western countries. In the US, it has been estimated that about 200,000 men were diagnosed with CaP in 2009, with more than 27,000 dying from the disease.
Already a subscriber? Log in
The Star Festive Promo: Get 35% OFF Digital Access
Cancel anytime. Ad-free. Unlimited access with perks.
